This year’s BELLEROPHON annual meeting took place 07-08 July in Heidelberg, Germany. Staying at the ‘Internationales Wissenschaftsforum’ in the old town of Heidelberg allowed the participants to discuss the scientific progress in a charming and pleasant atmosphere.
The Japanese Global Health Innovative Technology Fund (GHIT) has produced two short videos https://youtu.be/Nq6u_cCzn4k and https://youtu.be/dtZPEBG9ljM shot on location in Uganda, South East Asia and Burkina Faso, the latter being where the SEmalvac project, funded by GHIT, is ongoing. The main objective is to assess the safety and immunogenicity of the recombinant Escherichia coli BK-SE36 malaria vaccine candidate in healthy malaria exposed African children. GHIT support also aims to improve maternal health and child survival through innovative means and strategies. Health improvement will secure well being and productivity. These two movies stress the need to maintain a sustainable partnership.
The European & Developing Countries Clinical Trials' Partnership (EDCTP) invites nominations to the following awards: Scientific Leadership Award, Outstanding Female Scientist Award and Outstanding Research Team Award.
EVI extends a warm welcome to two new team members. Hilde Depraetere joined EVI on 1 July as Senior Project Manager, and yesterday 6 July Leah Williams commenced duties as Programme Manager Assistant.
The second EDUFLUVAC workshop on experimental animal models for universal influenza vaccines took place on 23-24 June 2016 at the Biomedical Primate Research Centre, Rijswijk, The Netherlands. The workshop was organised by EDUFLUVAC, EU - Framework programme 7 funded project with the financial support of Sanofi Pasteur and Viroclinics.
The following products are now available on the The National Institute for Biological Standards and Control (NIBSC) website:
Influenza Virus Infectious NIBRG-306 ( Influenza Reagent )
23-06-2016 01:00 AM BST
- 1 of 24